Heron Therapeutics: Q3 Earnings Snapshot
In this article:
SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $25 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 17 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The pharmaceutical company posted revenue of $31.4 million in the period.
Heron Therapeutics expects full-year revenue in the range of $123 million to $125 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX
